Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.
Adv Sci (Weinh). 2023 Dec;10(34):e2304818. doi: 10.1002/advs.202304818. Epub 2023 Oct 20.
Adv Sci (Weinh). 2023.
PMID: 37863812
Free PMC article.
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine.
Lopes de Assis F, Hoehn KB, Zhang X, Kardava L, Smith CD, El Merhebi O, Buckner CM, Trihemasava K, Wang W, Seamon CA, Chen V, Schaughency P, Cheung F, Martins AJ, Chiang CI, Li Y, Tsang JS, Chun TW, Kleinstein SH, Moir S.
Lopes de Assis F, et al.
Cell Rep. 2023 Jul 25;42(7):112780. doi: 10.1016/j.celrep.2023.112780. Epub 2023 Jul 12.
Cell Rep. 2023.
PMID: 37440409
Free PMC article.
Item in Clipboard
Broadly neutralizing antibodies target the coronavirus fusion peptide.
Dacon C, Tucker C, Peng L, Lee CD, Lin TH, Yuan M, Cong Y, Wang L, Purser L, Williams JK, Pyo CW, Kosik I, Hu Z, Zhao M, Mohan D, Cooper AJR, Peterson M, Skinner J, Dixit S, Kollins E, Huzella L, Perry D, Byrum R, Lembirik S, Drawbaugh D, Eaton B, Zhang Y, Yang ES, Chen M, Leung K, Weinberg RS, Pegu A, Geraghty DE, Davidson E, Douagi I, Moir S, Yewdell JW, Schmaljohn C, Crompton PD, Holbrook MR, Nemazee D, Mascola JR, Wilson IA, Tan J.
Dacon C, et al.
Science. 2022 Aug 12;377(6607):728-735. doi: 10.1126/science.abq3773. Epub 2022 Jul 12.
Science. 2022.
PMID: 35857439
Free PMC article.
Item in Clipboard
Early human B cell signatures of the primary antibody response to mRNA vaccination.
Kardava L, Rachmaninoff N, Lau WW, Buckner CM, Trihemasava K, Blazkova J, Lopes de Assis F, Wang W, Zhang X, Wang Y, Chiang CI, Narpala S, McCormack GE, Liu C, Seamon CA, Sneller MC, O'Connell S, Li Y, McDermott AB, Chun TW, Fauci AS, Tsang JS, Moir S.
Kardava L, et al.
Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2204607119. doi: 10.1073/pnas.2204607119. Epub 2022 Jun 27.
Proc Natl Acad Sci U S A. 2022.
PMID: 35759653
Free PMC article.
Item in Clipboard
One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization.
Gu M, Torres JL, Li Y, Van Ry A, Greenhouse J, Wallace S, Chiang CI, Pessaint L, Jackson AM, Porto M, Kar S, Li Y, Ward AB, Wang Y.
Gu M, et al.
Emerg Microbes Infect. 2021 Dec;10(1):2016-2029. doi: 10.1080/22221751.2021.1994354.
Emerg Microbes Infect. 2021.
PMID: 34651563
Free PMC article.
Item in Clipboard
Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization.
Wang Y, Howell KA, Brannan J, Agans KN, Turner HL, Wirchnianski AS, Kailasan S, Fusco M, Galkin A, Chiang CI, Zhao X, Saphire EO, Chandran K, Ward AB, Dye JM, Aman MJ, Geisbert TW, Li Y.
Wang Y, et al.
J Virol. 2021 Mar 25;95(8):e01907-20. doi: 10.1128/JVI.01907-20. Epub 2021 Feb 3.
J Virol. 2021.
PMID: 33536172
Free PMC article.
Item in Clipboard
Cite
Cite